Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-20-078440

Chief Financial Officer bought 777 shares at $76.64 ($59,549)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Pizzie Nick Chief Financial Officer 2020-06-29 Purchase +777 $76.64 $59,549 41,217 D
Open-market purchases · 777 sh · avg $76.64 · $59,549
Loading xslF345X03/a4.xml…